前列腺癌
医学
前列腺切除术
肿瘤科
放射治疗
雄激素剥夺疗法
癌症
内科学
疾病
转移
前列腺
作者
Mamello Sekhoacha,Keamogetswe Riet,Paballo Motloung,Lemohang Gumenku,Ayodeji M. Adegoke,Samson S. Mashele
出处
期刊:Molecules
[MDPI AG]
日期:2022-09-05
卷期号:27 (17): 5730-5730
被引量:305
标识
DOI:10.3390/molecules27175730
摘要
Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options.
科研通智能强力驱动
Strongly Powered by AbleSci AI